Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$1.22 - $4.83 $75,715 - $299,759
62,062 New
62,062 $76,000
Q2 2022

Aug 09, 2022

BUY
$2.22 - $4.54 $3,005 - $6,147
1,354 Added 12.37%
12,301 $27,000
Q1 2022

May 17, 2022

SELL
$3.58 - $4.98 $120,760 - $167,985
-33,732 Reduced 75.5%
10,947 $46,000
Q4 2021

Feb 17, 2022

BUY
$4.17 - $7.09 $186,311 - $316,774
44,679 New
44,679 $214,000
Q3 2021

Nov 12, 2021

SELL
$5.87 - $7.85 $101,674 - $135,969
-17,321 Closed
0 $0
Q2 2021

Sep 17, 2021

BUY
$6.69 - $9.0 $31,964 - $43,002
4,778 Added 38.09%
17,321 $130,000
Q1 2021

May 19, 2021

SELL
$8.26 - $11.4 $178,886 - $246,889
-21,657 Reduced 63.32%
12,543 $104,000
Q4 2020

Feb 24, 2021

BUY
$8.21 - $18.59 $57,355 - $129,869
6,986 Added 25.67%
34,200 $290,000
Q1 2018

May 14, 2018

BUY
$4.91 - $7.72 $133,620 - $210,092
27,214 New
27,214 $157,000

Others Institutions Holding MESO

About MESOBLAST LTD


  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $1.34B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.